Correspondence | Published:

Reply to Johnson et al. Regarding Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis

The American Journal of Gastroenterology (2018) | Download Citation

Subjects

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Johnson FR, Reed S, Gonzalez JM. Letter to the editor regarding optimizing selection of biologics in inflammatory bowel disease: development of an online patient decision aid using conjoint analysis. Am J Gastroenterol. 2018; epub ahead of print.

  2. 2.

    Almario CV, Keller MS, Chen M, et al. Optimizing selection of biologics in inflammatory bowel disease: development of an online patient decision aid using conjoint analysis. Am J Gastroenterol. 2018;113:58–71.

  3. 3.

    Bernstein KI, Promislow S, Carr R, et al. Information needs and preferences of recently diagnosed patients with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:590–8.

  4. 4.

    Steinhart AH, Ewe K, Griffiths AM, et al. Corticosteroids for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev. 2003; Issue 4: CD000301.

  5. 5.

    Siegel CA. Review article: explaining risks of inflammatory bowel disease therapy to patients. Aliment Pharmacol Ther. 2011;33:23–32.

Download references

Author information

Affiliations

  1. Division of Health Services Research, Cedars-Sinai Medical Center, Los Angeles, CA, USA

    • Christopher V. Almario MD, MSHPM
    • , Michelle S. Chen MPH
    •  & Brennan M. R. Spiegel MD, MSHS
  2. Cedars-Sinai Center for Outcomes Research and Education (CS-CORE), Los Angeles, CA, USA

    • Christopher V. Almario MD, MSHPM
    • , Michelle S. Chen MPH
    •  & Brennan M. R. Spiegel MD, MSHS
  3. Division of Digestive and Liver Diseases, Cedars-Sinai Medical Center, Los Angeles, CA, USA

    • Christopher V. Almario MD, MSHPM
    •  & Brennan M. R. Spiegel MD, MSHS
  4. Division of Informatics, Cedars-Sinai Medical Center, Los Angeles, CA, USA

    • Christopher V. Almario MD, MSHPM
    •  & Brennan M. R. Spiegel MD, MSHS
  5. Department of Health Policy and Management, UCLA Fielding School of Public Health, Los Angeles, CA, USA

    • Michelle S. Chen MPH
    •  & Brennan M. R. Spiegel MD, MSHS

Authors

  1. Search for Christopher V. Almario MD, MSHPM in:

  2. Search for Michelle S. Chen MPH in:

  3. Search for Brennan M. R. Spiegel MD, MSHS in:

Guarantor of the article

Brennan M.R. Spiegel, MD, MSHS

Specific author contributions

Christopher V. Almario, Michelle S. Chen, and Brennan M.R. Spiegel—drafting and final approval of the Letter to the Editor.

Financial support

None.

Potential competing interests

Brennan M.R. Spiegel has received grant support from Takeda Pharmaceuticals. Christopher V. Almario has received a one-time speaker’s fee from Takeda Pharmaceuticals. Michelle S. Chen does not have any relevant disclosures.

Corresponding author

Correspondence to Brennan M. R. Spiegel MD, MSHS.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/s41395-018-0279-1